QIAGEN Inc. and BioBay Announce Translational Medicine JV

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 28, 2013 -- Qiagen, a Dutch molecular diagnostics company that provides sample and assay technologies, will set up a translational medicine R&D JV with Suzhou’s BioBay Life Science Park. The JV will provide discovery and validation of biomarkers from which it will create companion diagnostics for the Chinese market. Its customers are expected to be domestic and international pharma that are located in BioBay and elsewhere in China. More details....

Stock Symbol: (NSDQ: QGEN)

Help employers find you! Check out all the jobs and post your resume.